Antibiotic therapy in nongastrointestinal MALT lymphoma: A review of the literature

Blood

Volumn 122, Issue 8, 2013, Pages 1350-1357

  Kiesewetter, Barbara ^a   Raderer, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CEFOTAXIME; CEFRADINE; CEFTRIAXONE; CHLORAMBUCIL; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXYCYCLINE; LANSOPRAZOLE; METRONIDAZOLE; NITROFURANTOIN; OMEPRAZOLE; PEGINTERFERON ALPHA2A; PREDNISOLONE; PROTON PUMP INHIBITOR; TRIMETHOPRIM; VINCRISTINE; ANTIINFECTIVE AGENT;

ACHROMOBACTER; ADNEXA DISEASE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BACTERIAL INFECTION; BACTERIUM DETECTION; BLADDER; BORRELIA BURGDORFERI; BORRELIA INFECTION; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; DIZZINESS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; ESCHERICHIA COLI; FOLLOW UP; GASTROSCOPY; HASHIMOTO DISEASE; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; INFECTION; LICHEN PLANUS; LONG TERM CARE; LUNG MYCOSIS; LYME DISEASE; LYMPHOID TISSUE; MARGINAL ZONE LYMPHOMA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MYCOPLASMA PNEUMONIAE; NAUSEA; NONHUMAN; OCULAR ADNEXA MALT LYMPHOMA; PAROTID GLAND CARCINOMA; PHASE 2 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PSEUDOLYMPHOMA; PUBLISHING; RETROSPECTIVE STUDY; REVIEW; SJOEGREN SYNDROME; SKIN LYMPHOMA; STOMACH BIOPSY; STOMATITIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION; CHLAMYDOPHILA INFECTION; CLINICAL TRIAL (TOPIC); DISEASE COURSE; EYE TUMOR; REMISSION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PSITTACI; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; DOXYCYCLINE; EYE NEOPLASMS; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84886814238     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-486522     Document Type: Review

References (51)

1. Jaffe ES, Harris NL, Stein H, et al. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008: 158-166.
2. Isaacson PG, Chott A, Nakumura S., et al. Extranodal marginal cell lymphoma of mucosa-associated tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008: 214-219.
3. Wöhrer S., Troch M, Streubel B., et al. MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia. 2007; 21(8): 1812-1818. (Pubitemid 47086770)
4. Arcaini L, Burcheri S, Rossi A., et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol. 2007; 18(2): 346-350. (Pubitemid 46323104)
5. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003; 125(6): 1723-1732. (Pubitemid 37500437)
6. Suarez F, Lortholary O, Hermine O., Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006; 107(8): 3034-3044.
7. Ruskoné-Fourmestraux A, Fischbach W, Aleman BM, et al; EGILS group. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011; 60(6): 747-758.
8. Wotherspoon AC, Doglioni C, Diss T.C., et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993; 342(8871): 575-577. (Pubitemid 23259233)
9. Levy M, Copie-Bergman C, Traulle C., et al.; Groupe d'Etude des Lymphomes de l'Adulte (GELA). Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol. 2002; 97(2): 292-297. (Pubitemid 34160752)
10. Wündisch T., Thiede C, Morgner A., et al. Longterm follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005; 23(31): 8018-8024. (Pubitemid 46657403)
11. Ferreri AJ, Guidoboni M, Ponzoni M., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004; 96(8): 586-594. (Pubitemid 38584982)
12. Cerroni L, Zöchling N, Pütz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997; 24(8): 457-461. (Pubitemid 27432373)
13. Lecuit M, Abachin E, Martin A., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med. 2004; 350(3): 239-248. (Pubitemid 38067636)
14. Ferreri AJ, Govi S, Pasini E., et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012; 30(24): 2988-2994.
15. Ferreri AJ, Dognini GP, Ponzoni M, et al. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma. Ann Oncol. 2008; 19(1): 194-195.
16. Ferreri AJ, Ponzoni M, Guidoboni M., et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst. 2006; 98(19): 1375-1382. (Pubitemid 44530714)
17. Ferreri AJ, Ponzoni M, Guidoboni M., et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol. 2005; 23(22): 5067-5073. (Pubitemid 46224014)
18. Govi S, Dognini GP, Licata G, et al. Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial. Br J Haematol. 2010; 150(2): 226-229.
19. Kim TM, Kim KH, Lee M.J., et al. First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors. Cancer Sci. 2010; 101(5): 1199-1203.
20. Grünberger B, Hauff W, Lukas J, et al. 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol. 2006; 17(3): 484-487. (Pubitemid 43329587)
21. Abramson DH, Rollins I, Coleman M. Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics. Am J Ophthalmol. 2005; 140(4): 729-730. (Pubitemid 41455321)
22. Yeung L, Tsao YP, Chen P.Y., Kuo TT, Lin KK, Lai LJ. Combination of adult inclusion conjunctivitis and mucosa-associated lymphoid tissue (MALT) lymphoma in a young adult. Cornea. 2004; 23(1): 71-75. (Pubitemid 38031878)
23. Madico G, Quinn TC, Boman J, Gaydos CA. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol. 2000; 38(3): 1085-1093. (Pubitemid 30140565)
24. Grünberger B, Wöhrer S, Streubel B, et al. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol. 2006; 24(9): 1370-1375. (Pubitemid 46622000)
25. Ferreri AJ, Ponzoni M, Viale E., et al. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications. Hematol Oncol. 2006; 24(1): 33-37.
26. Colli C, Leinweber B, Müllegger R, Chott A., Kerl H, Cerroni L. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004; 31(3): 232-240. (Pubitemid 38230565)
27. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol. 2000; 24(9): 1279-1285.
28. Ponzoni M, Ferreri AJ, Mappa S, et al. Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas. Oncologist. 2011; 16(11): 1582-1588.
29. Takino H, Li C, Hu S., et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol. 2008; 21(12): 1517-1526.
30. de la Fouchardiere A, Vandenesch F, Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. Am J Surg Pathol. 2003; 27(5): 702-703. (Pubitemid 36514484)
31. Fühler M., Ottmann KW, Tronnier M. Cutaneous marginal zone lymphoma (SALT) and infection with Borrelia burgdorferi [in German]. Hautarzt. 2010; 61(2): 145-147.
32. Monari P, Farisoglio C, Calzavara Pinton PG. Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report. Dermatology. 2007; 215(3): 229-232. (Pubitemid 47378990)
33. Roggero E, Zucca E, Mainetti C., et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol. 2000; 31(2): 263-268. (Pubitemid 30090662)
34. Kütting B., Bonsmann G, Metze D., Luger TA, Cerroni L. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2α. J Am Acad Dermatol. 1997; 36(2, pt 2): 311-314. (Pubitemid 27078893)
35. Aberer E, Fingerle V, Wutte N., Fink-Puches R, Cerroni L. Within European margins. Lancet. 2011; 377(9760): 178.
36. Garbe C, Stein H, Dienemann D., Orfanos CE. Borrelia burgdorferi- associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol. 1991; 24(4): 584-590.
37. Chanudet E, Adam P, Nicholson A.G., et al. Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma. Br J Cancer. 2007; 97(7): 949-951. (Pubitemid 47519320)
38. Aigelsreiter A, Gerlza T, Deutsch A.J., et al. Chlamydia psittaci infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions. Am J Clin Pathol. 2011; 135(1): 70-75.
39. Sammassimo S, Pruneri G, Adam P., et al. Potential pathogenetic role of Achromobacter (Alcaligenes) xylosoxidans in primary extranodal marginal zone lymphoma of the lung (BALT-Lymphoma): update of the results of a retrospective analysis on behalf of IELSG [abstract]. Blood. 2011; 118(21). Abstract 880.
40. Ishimatsu Y, Mukae H, Matsumoto K., et al. Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest. 2010; 138(3): 730-733.
41. Troch M, Streubel B, Petkov V., Turetschek K, Chott A, Raderer M. Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res. 2007; 27(5B): 3633-3637. (Pubitemid 47607512)
42. Gaur S, Trayner E, Aish L., Weinstein R. Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection. Am J Hematol. 2004; 77(1): 22-25. (Pubitemid 39108792)
43. Iwai H, Nakamichi N, Nakae K., et al. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication. Laryngoscope. 2009; 119(8): 1491-1494.
44. Arima N, Tsudo M. Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Haematol. 2003; 120(5): 790-792. (Pubitemid 36315100)
45. Alkan S, Karcher DS, Newman M.A., Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet. 1996; 348(9022): 268-269. (Pubitemid 26254210)
46. Fujimura M, Chin K, Sekita N., et al. Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report [in Japanese]. Hinyokika Kiyo. 2008; 54(12): 783-786.
47. van den Bosch J, Kropman RF, Blok P, Wijermans PW. Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori. Eur J Haematol. 2002; 68(3): 187-188. (Pubitemid 34620609)
48. Oscier D, Bramble J, Hodges E., Wright D. Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy. J Clin Oncol. 2002; 20(3): 882. (Pubitemid 34111406)
49. Dagklis A, Ponzoni M, Govi S., et al. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Leukemia. 2012; 26(4): 814-821.
50. Chanudet E, Zhou Y, Bacon C.M., et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006; 209(3): 344-351. (Pubitemid 43997743)
51. Kiesewetter B, Müllauer L, Streubel B., et al. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects. Ann Hematol. 2012; 91(11): 1817-1818.